Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05324397 · ClinicalTrials.gov registry record · NA

Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis (CLARITY)

A NA study of Chronic Rhinitis, sponsored by Neurent Medical.

Completed
Registry status
NA
Development phase
36
Enrollment target
4
Study locations

NCT05324397 is a NA study of Chronic Rhinitis that has completed, run by Neurent Medical. The registered enrollment target is 36 participants, below the 91-participant average among 6 other Chronic Rhinitis trials with a reported enrollment target (60% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05324397, a NA study of Chronic Rhinitis, has completed, sponsored by Neurent Medical.

COMPLETED
Registry status
NA
Development phase
36 participants
Enrollment target
4
Study locations

Study Summary

The CLARITY Study is a prospective, single-arm, multicenter safety and efficacy study of the Neurent Medical NEUROMARK System in subjects with chronic rhinitis.

Conditions Studied

Chronic Rhinitis

Interventions

  • DEVICE NEUROMARK System

Study Locations (4)

Alabama

  • Alabama Nasal and Sinus Center - Birmingham

Maryland

  • Centers for Advanced ENT Care - Baltimore

Pennsylvania

  • Specialty Physician Associates - Bethlehem

Washington

  • ENT & Allergy Associcates - Puyallup

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2022-03-14
Est. Completion 2023-10-04
Phase NA

Sponsor

Neurent Medical

5 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05324397

The ClinicalTrials.gov registry entry for NCT05324397 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 91-participant average among 6 other Chronic Rhinitis trials with a reported enrollment target (60% lower). The listed sponsor is Neurent Medical, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Rhinitis appearing as the primary indexed condition, and to 1 intervention - of which NEUROMARK System is the first listed.

NCT05324397 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Alabama, Maryland, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05324397 about?

NCT05324397 is a clinical study titled "Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis (CLARITY)". The CLARITY Study is a prospective, single-arm, multicenter safety and efficacy study of the Neurent Medical NEUROMARK System in subjects with chronic rhinitis.

What is the current status of trial NCT05324397?

This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2022-03-14. Estimated completion is 2023-10-04.

What conditions does trial NCT05324397 study?

This clinical trial studies the following conditions: Chronic Rhinitis.

What interventions are being tested in trial NCT05324397?

The interventions under investigation include: NEUROMARK System (DEVICE).

Who is sponsoring clinical trial NCT05324397?

This trial is sponsored by Neurent Medical, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05324397 being conducted?

This trial has 4 study locations across Alabama, Maryland, Pennsylvania, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Chronic Rhinitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Chronic Rhinitis

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.